Stem Cell Authority Stock Buy Hold or Sell Recommendation
| SCAL Stock | USD 0.0001 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Stem Cell Authority is 'Strong Sell'. The recommendation algorithm takes into account all of Stem Cell's available fundamental, technical, and predictive indicators you will find on this site.
Check out Stem Cell Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Stem and provide practical buy, sell, or hold advice based on investors' constraints. Stem Cell Authority. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Stem |
Execute Stem Cell Buy or Sell Advice
The Stem recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Stem Cell Authority. Macroaxis does not own or have any residual interests in Stem Cell Authority or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Stem Cell's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weakest | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Stem Cell Trading Alerts and Improvement Suggestions
| Stem Cell Authority generated a negative expected return over the last 90 days | |
| Stem Cell Authority has high historical volatility and very poor performance | |
| Stem Cell Authority has some characteristics of a very speculative penny stock |
Stem Cell Returns Distribution Density
The distribution of Stem Cell's historical returns is an attempt to chart the uncertainty of Stem Cell's future price movements. The chart of the probability distribution of Stem Cell daily returns describes the distribution of returns around its average expected value. We use Stem Cell Authority price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Stem Cell returns is essential to provide solid investment advice for Stem Cell.
| Mean Return | -0.78 | Value At Risk | 0.00 | Potential Upside | 0.00 | Standard Deviation | 6.25 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Stem Cell historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Stem Cell Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Stem Cell or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Stem Cell's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Stem pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.73 | |
β | Beta against Dow Jones | -0.88 | |
σ | Overall volatility | 6.25 | |
Ir | Information ratio | -0.14 |
Stem Cell Volatility Alert
Stem Cell Authority is displaying above-average volatility over the selected time horizon. Stem Cell Authority appears to be a penny stock. Although Stem Cell Authority may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Stem Cell Authority or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Stem instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Stem Cell Fundamentals Vs Peers
Comparing Stem Cell's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Stem Cell's direct or indirect competition across all of the common fundamentals between Stem Cell and the related equities. This way, we can detect undervalued stocks with similar characteristics as Stem Cell or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Stem Cell's fundamental indicators could also be used in its relative valuation, which is a method of valuing Stem Cell by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Stem Cell to competition |
| Fundamentals | Stem Cell | Peer Average |
| Return On Asset | 0.49 | -0.14 |
| Profit Margin | 0.55 % | (1.27) % |
| Operating Margin | 0.55 % | (5.51) % |
| Current Valuation | 9.15 M | 16.62 B |
| Shares Outstanding | 348.71 M | 571.82 M |
| Price To Earning | 2.00 X | 28.72 X |
| Price To Sales | 1.05 X | 11.42 X |
| Revenue | 3.33 M | 9.43 B |
| Gross Profit | 2.27 M | 27.38 B |
| Net Income | 1.83 M | 570.98 M |
| Cash And Equivalents | 39.84 K | 2.7 B |
| Total Debt | 675.1 K | 5.32 B |
| Debt To Equity | 4.88 % | 48.70 % |
| Current Ratio | 1.12 X | 2.16 X |
| Earnings Per Share | 0.01 X | 3.12 X |
| Number Of Employees | 1 | 18.84 K |
| Beta | -71.45 | -0.15 |
| Market Capitalization | 2.34 M | 19.03 B |
| Total Asset | 3.99 M | 29.47 B |
| Z Score | 1.8 | 8.72 |
| Net Asset | 3.99 M |
Stem Cell Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Stem . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About Stem Cell Buy or Sell Advice
When is the right time to buy or sell Stem Cell Authority? Buying financial instruments such as Stem Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Stem Cell in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Target Risk ETFs Thematic Idea Now
Target Risk ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Risk ETFs theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Risk ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Stem Pink Sheet
Stem Cell financial ratios help investors to determine whether Stem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stem with respect to the benefits of owning Stem Cell security.